Aurobindo’s TheraNym Biologics Signs Pact with MSD for Biologics Manufacturing MM Desk 1 June, 2024 Aurobindo Pharma Limited has announced that its wholly-owned subsidiary, TheraNym Biologics Private Limited, has entered Read More
Aurobindo Pharma reports increase in Q4 PAT MM Desk 27 May, 2024 Aurobindo Pharma has announced a robust financial performance for the fourth quarter ending March 31, Read More
Aurobindo Pharma’s Rajasthan Facility Wraps Up US FDA Audit with 9 Observations MM Desk 6 May, 2024 Aurobindo Pharma, a leading pharmaceutical company, has announced the conclusion of a United States Food Read More
Aurobindo Pharma’s COVID-19 drug ‘Molnupiravir’ launched in India MM Desk 7 January, 2022 Read More